New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Caribou Biosciences, Inc.
Caribou Biosciences, Inc.
Industry: Life Sciences ・ $CRBU on Nasdaq ・ Market Cap: Small
Top Executive Recent Purchases
New Purchase Insider
Top Executive Recent Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
TRADES PURCHASE/SALE
Sector Average
1 / 3
2.19 / 7.65
INSIDER BUYERS/SELLERS
Sector Average
1 / 3
1.2 / 2.5
SHARES PURCHASED/SOLD
Transaction Average
17,360 / 10,692
17,360 / 3,564
VALUE PURCHASED/SOLD
Transaction Average
$24,651 / $14,434
$24,651 / $4,811
PURCHASE RANGE$24,651.2 - $24,651.2
SALE RANGE$4,811.4 - $4,811.4
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
2 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
0 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
0%
DIRECTORS
100%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX
Sector Average
N/A
0.2
VALUE GINI INDEX
Sector Average
N/A
0.206
1Y SALE DISTRIBUTION
sale distribution by individual insiders
0%
DIRECTORS
100%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX
Sector Average
N/A
0.295
VALUE GINI INDEX
Sector Average
0
0.288
Caribou Biosciences, Inc. 1Y Trade Transactions
Submission Date
Period of Report
InsiderPositionTotal ValueSharesShare PriceOwnership % ChangeShares OwnedPost Day Stock ChangePost Week Stock Change
2025-02-21
2025-02-20
MCCLUNG BARBARA G
Officer
-$4,811
3,564
$1.35
-0.8%
443,502
N/A
N/A
2025-02-21
2025-02-20
Khan Ruhi Ahmad
Officer
-$4,811
3,564
$1.35
-5.06%
66,936
N/A
N/A
2025-02-21
2025-02-20
Kanner Steven
Officer
-$4,811
3,564
$1.35
-0.82%
431,556
N/A
N/A
2025-01-30
2025-01-29
Ryali Sriram
Officer
+$24,651
17,360
$1.42
+new%
17,360
+11.45%
+8.40%
Get Feature Updates
Subscribe to our newsletter and receive the latest updates. You will get pre-access to new features